| Code | 2733F | ||||||||||
| MA number | 09/0043/26-S | ||||||||||
| Product Form: | sol por 14x15 ml/20 mg (fľ.HDPE dvojkom.) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Mutual recognition procedure | ||||||||||
| MAH, country: | INN-FARM d.o.o., Slovenia | ||||||||||
| Therapeutic Class: | 09 - ANTACIDA (VRÁTANE ANTIULCEROSNYCH LIEČIV) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | bottle HDPP | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(3) hybrid application |
| MA issued: | 16.02.2026 |
| Validity: | 16.02.2031 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| PIL: |
PIL_Lappoxo perorálny roztok_02_2026.pdf
|
| SPC: |
SPC_Lappoxo perorálny roztok_02_2026.pdf
|
| Safety feature | Yes |
| Data update: | 26.02.2026 |
